It was appreciated that biallelic DICER1 mutations were probably insufficient for the progression of type I PPB to types II or III and that an additional mutation(s) was probably necessary and these include TP53 and NRAS mutations10,28–31. The gene discussed is TP53; the disease is pleuropulmonary blastoma.